Filtering by:
GeneticsFDA Approves Rozlytrek (Entrectinib) for Tumors With Certain Genetic Markers
The US Food and Drug Administration (FDA) has approved Rozlytrek (entrectinib) for adults and adolescents with tumors that test positive for NTRK gene changes, which can help cancerous tumors grow.
FDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.
FDA Approves Consumer Test for Certain BRCA Mutations
The US Food and Drug Administration (FDA) has approved the first direct-to-consumer tests for certain BRCA1 and BRCA2 gene mutations.
Genetic Testing and Counseling for Breast Cancer Can Help Guide Tough Decisions
Genetic testing can answer some of the questions faced by women newly diagnosed with breast cancer. But what precedes and follows that test is vital, experts say. Many women have been helped by genetic counseling, a detailed discussion by a trained professional of a woman’s specific circumstances.
Women Face Gaps in Use of Genetic Counseling to Make Breast Cancer Treatment Decisions
Genetic testing is an important tool in making breast cancer treatment decisions, and it's more widely available today than ever before. But many women are still not getting all the information they need.